These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 86540)

  • 21. Effect of leupeptin on the intracellular degradation of asialofetuin in isolated rat hepatocytes.
    Berg T; Tolleshaug H
    Acta Biol Med Ger; 1981; 40(10-11):1599-602. PubMed ID: 6177139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracellular degradation of 125I-labelled asialo-glycoproteins in rat hepatocytes: effect of leupeptin on subcellular distribution of asialo-fetuin.
    Berg T; Ose T; Ose L; Tolleshaug H
    Int J Biochem; 1981; 13(3):253-9. PubMed ID: 6163669
    [No Abstract]   [Full Text] [Related]  

  • 23. 125I-Insulin internalization by perfused rat liver: comparison of its subcellular distribution with that of a lysosomally targeted molecule, 125I-asialofetuin.
    Ward WF
    Horm Metab Res; 1984 Oct; 16(10):509-12. PubMed ID: 6209195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of lysosomal inhibitors on 125I-insulin and 125I-asialofetuin degradation by the isolated, perfused rat liver and isolated rat hepatocytes.
    Ward WF; Moss AL
    Diabetes; 1985 May; 34(5):446-51. PubMed ID: 2580748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of leupeptin on intracellular digestion of asialofetuin in rat hepatocytes.
    Tolleshaug H; Berg T
    Exp Cell Res; 1981 Jul; 134(1):207-17. PubMed ID: 6166491
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibition of 125I-asialofetuin catabolism by leupeptin in the perfused rat liver and in vivo.
    Dunn WA; LaBadie JH; Aronson NN
    J Biol Chem; 1979 May; 254(10):4191-6. PubMed ID: 86540
    [No Abstract]   [Full Text] [Related]  

  • 27.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 28.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 29.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 30.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.